V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency

Clinical trial NCT06954441 · RECRUITING

Trial details

NCT number: NCT06954441
Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Immunodeficiencies Primary Immunodeficiencies (PID)Agammaglobulinemia

Start date: 2025-08-15
Primary completion: 2026-09-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.